Related Experiment Videos
Valve replacement for appetite suppressant-induced valvular heart disease
S S Biswas1, C L Donovan, J M Forbess
1Division of Thoracic and Cardiovascular Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Valvular heart disease associated with the use of appetite-suppressant medication is a recently described clinical entity. Although the mechanism of valvular injury remains elusive pathologically, the valvular abnormalities resemble those observed in carcinoid syndrome. The incidence of clinically evident valvular heart disease is low with short-term (less than 3 months) exposure to appetite-suppressant drugs. Prolonged exposure to higher doses in addition to combination drug therapy confers an excess risk for valvular pathologic changes. We report the case of a patient with severe mitral regurgitation who had short-term exposure (3 weeks) to the combination of fenfluramine (20 mg) and phenteramine (15 mg).
Insights
Valvular heart disease linked to appetite suppressants is a new concern. Prolonged use or combination therapy increases the risk of heart valve damage, even with short-term exposure.
Area of Science:
- Cardiology
- Pharmacology
- Pathology
Background:
- Valvular heart disease is a newly recognized clinical entity associated with appetite-suppressant medications.
- The pathological mechanism of valvular injury is not fully understood.
- Observed valvular abnormalities share similarities with those seen in carcinoid syndrome.
Observation:
- Clinically significant valvular heart disease is uncommon with short-term (under 3 months) use of appetite suppressants.
- Extended exposure, higher dosages, and combination drug regimens elevate the risk of valvular pathology.
- A case report details severe mitral regurgitation in a patient with brief (3 weeks) exposure to fenfluramine and phentermine combination therapy.
Findings:
- Short-term use of appetite suppressants can lead to severe mitral regurgitation.
- Combination therapy with fenfluramine and phentermine, even for a short duration, may pose a risk.
- The study highlights a potential link between specific appetite suppressants and acute valvular dysfunction.
Implications:
- Further research is needed to elucidate the mechanism of drug-induced valvular injury.
- Clinical vigilance for valvular heart disease is warranted in patients using appetite suppressants, especially combination therapies.
- This case underscores the importance of considering medication history in patients presenting with valvular abnormalities.